Largest biotech companies by net assets
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
Gilead Sciences leads the 24 biotech companies ranked by net assets, at SEK 230.5B, ahead of BioNTech (SEK 216.5B) and Biogen (SEK 185.3B). Figures as of 18 Nov 2026, 17:50 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 24
- First
- Gilead SciencesSEK 230.5B
- Median
- SEK 20.4B
- Combined market value
- SEK 8.55T
- Countries
- 5
Market values as of .
All countries▾
All sectors▾
Biotech▾
| # | Company | Net assets ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Gilead SciencesGILD · Health Care | SEK 230.5B | SEK 2.13T | SEK 1,720.52 | 0.45% down | 33% up | ||
| 2 | BioNTechBNTX · Health Care | SEK 216.5B | SEK 211.8B | SEK 854.42 | 0.81% down | 16% down | ||
| 3 | BiogenBIIB · Health Care | SEK 185.3B | SEK 378.2B | SEK 2,558.34 | 0.49% up | 49% up | ||
| 4 | AmgenAMGN · Health Care | SEK 87.9B | SEK 2.46T | SEK 4,539.69 | 2.34% down | 34% up | ||
| 5 | ModernaMRNA · Health Care | SEK 87.8B | SEK 830.8B | SEK 2,053.17 | 2.20% down | 755% up | ||
| 6 | argenxARGX · Health Care | SEK 74.3B | SEK 604B | SEK 9,604.10 | 0.15% down | 4% up | ||
| 7 | QiagenQGEN · Health Care | SEK 38.4B | SEK 104B | SEK 503.80 | 0.24% down | 12% up | ||
| 8 | Neurocrine BiosciencesNBIX · Health Care | SEK 33B | SEK 167.1B | SEK 1,651.29 | 1.96% down | 20% up | ||
| 9 | VaxcytePCVX · Health Care | SEK 27.3B | SEK 94.6B | SEK 597.45 | 0.92% down | 22% up | ||
| 10 | ExelixisEXEL · Health Care | SEK 21.9B | SEK 171.5B | SEK 702.70 | 1.06% up | 63% up | ||
| 11 | Bio-TechneTECH · Health Care | SEK 21.4B | SEK 116.1B | SEK 738.85 | 0.21% up | 26% up | ||
| 12 | RepligenRGEN · Health Care | SEK 21.4B | SEK 111.9B | SEK 1,750.36 | 6.32% up | 5% up | ||
| 13 | CRISPR TherapeuticsCRSP · Health Care | SEK 19.5B | SEK 41.5B | SEK 427.36 | 4.86% up | 21% down | ||
| 14 | Revolution MedicinesRVMD · Health Care | SEK 16.6B | SEK 350.3B | SEK 1,619.61 | 1.93% down | 131% up | ||
| 15 | Kymera TherapeuticsKYMR · Health Care | SEK 16B | SEK 106B | SEK 1,241.89 | 0.67% up | 87% up | ||
| 16 | Krystal BiotechKRYS · Health Care | SEK 12.4B | SEK 94.3B | SEK 3,182.79 | 5.02% up | 46% up | ||
| 17 | ImmunovantIMVT · Health Care | SEK 8.7B | SEK 70.4B | SEK 340.37 | 0.96% up | 43% up | ||
| 18 | CG OncologyCGON · Health Care | SEK 7.6B | SEK 74.1B | SEK 829.14 | 3.47% up | 85% up | ||
| 19 | Twist BioscienceTWST · Health Care | SEK 4.8B | SEK 81.5B | SEK 1,195.09 | 5.12% up | 340% up | ||
| 20 | Scholar Rock HoldingSRRK · Health Care | SEK 2.5B | SEK 58.6B | SEK 480.50 | 5.00% up | 14% up | ||
| 21 | Adaptive BiotechnologiesADPT · Health Care | SEK 2.2B | SEK 47.1B | SEK 290.93 | 0.60% up | 88% up | ||
| 22 | Kodiak SciencesKOD · Health Care | SEK 1.6B | SEK 64.7B | SEK 988.92 | 0.64% up | 396% up | ||
| 23 | Halozyme TherapeuticsHALO · Health Care | SEK 495.5M | SEK 111.7B | SEK 979.99 | 0.59% up | 37% up | ||
| 24 | ImmunityBioIBRX · Health Care | -SEK 5.1B | SEK 72.7B | SEK 68.32 | 7.51% up | 193% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Net assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 10.1511 SEK).
Questions and answers
Which biotech companies rank first by net assets?
Gilead Sciences (SEK 230.5B), BioNTech (SEK 216.5B) and Biogen (SEK 185.3B) are the top three of the 24 biotech companies ranked by net assets as of 18 Nov 2026, 17:50 UTC.
How many biotech companies are in this ranking?
24 are ranked by net assets.
What are these biotech companies worth together?
The 24 biotech companies ranked by net assets have a combined market value of SEK 8.55T as of 18 Nov 2026, 17:50 UTC.
What does ranking by net assets measure?
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest biotech companies by net assets”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=net-assets
Underlying data: Yahoo Finance; SEC EDGAR.